Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-[[4-fluoro-2-(5-methy-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4-,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitor

N-[[4-fluoro-2-(5-methy-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4-,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitor

US Patent 7511037 · Granted Mar 31, 2009

Estimated economic value: $106,118,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative dise2025
Imidazothiadiazole and imidazopyrazine derivatives as protease activated recepto2024
Imidazothiadiazole and imidazopyrazine derivatives as protease activated recepto2024
Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative dise2024
4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency v2022
Salts of prodrugs of piperazine and substituted piperidine antiviral agents2022
Salts of prodrugs of piperazine and substituted piperidine antiviral agents2022
Polypeptides targeting HIV fusion2021
Inhibitors of human immunodeficiency virus replication2021
Imidazothiadiazole and imidazopyrazine derivatives as protease activated recepto2020
Imidazothiadiazole and imidazopyrazine derivatives as protease activated recepto2020
Compounds useful as immunomodulators2020